Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/1997
10/09/1997CA2250110A1 Growth differentiation factor-14
10/09/1997CA2249206A1 Apo-2li and apo-3 apoptosis polypeptides
10/09/1997CA2248615A1 Monoclonal antibody that detects apoptotic antigen
10/09/1997CA2248550A1 Cytokine designated lerk-8
10/09/1997CA2222596A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines
10/08/1997EP0799891A1 Anti-Fas recombinant antibodies and DNA therefor
10/08/1997EP0799836A1 Novel monoclonal antibody having inhibitory effect on type ii phospholipase a2 and protein containing a part of the same
10/08/1997EP0799835A2 Anti-fibroblast growth factor-8 monoclonal antibody
10/08/1997EP0799315A2 Telomerase protein component
10/08/1997EP0799314A2 PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES
10/08/1997EP0799312A1 New 17-kda brucella abortus antigen, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
10/08/1997EP0799311A1 Human chemokine beta-9
10/08/1997EP0799244A1 A bifunctional or bivalent antibody fragment analogue
10/08/1997EP0580782B1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof
10/07/1997US5675063 Immortalized rabbit hybridoma fusion partner
10/07/1997US5675062 Mouse engrafted with histoincompatible artery which exhibits detectable arteriosclerosis with in 30 days of grafting
10/07/1997US5674994 Polynucleotides encoding the anti-PEM antibody BW835 variable domains and expression vectors
10/07/1997US5674984 Method for isolation of unclipped HIV envelope protein
10/07/1997US5674983 Natural human chorionic gonadotropin β-core molecule
10/07/1997US5674981 Human calcitonin receptor polypeptides
10/07/1997US5674978 Peptides derived from glutamic acid decarboxylase
10/07/1997US5674898 Methods and therapeutic compositions for treating cystic fibrosis
10/07/1997US5674844 Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
10/07/1997US5674841 Method for inhibiting growth of stem cells
10/07/1997US5674834 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
10/07/1997US5674754 Diagnostic assay for latent matrix metallo-proteinase No. 9 and use thereof in the diagnosis of rheumatoid and inflammatory arthritis and inflammatory bowel disease
10/07/1997US5674750 Continuous selective clonogenic expansion of relatively undifferentiated cells
10/07/1997US5674749 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-A, and uses thereof
10/07/1997US5674748 Human cyclin-dependent kinase-like proteins and methods of using the same
10/07/1997US5674734 Cell death protein
10/07/1997US5674719 Method for producing monoclonal antibodies specific to hair follicles
10/07/1997US5674712 Recombinant vector and use thereof for exocellular preparation of antibodies in single molecule form from Bacillus subtilis
10/07/1997US5674692 Methods for diabetes susceptibility assessment in asymptomatic patients
10/07/1997US5674690 Assaying in vitro tissue or body fluid sample for presence of immunoglobulin g antibodies against hydroxyfatty acid containing sulfatide to screen for multiple sclerosis, hiv infection, rheumatoid arthritis, systemic lupus erythematosis
10/07/1997US5674689 Human calcitonin receptor polypeptides and methods of use
10/07/1997US5674494 Treating non-malignant disease states with IL-2 receptor-specific substances
10/07/1997US5674493 Compositions and methods for targeting cells with A2R and A2R monoclonal antibodies
10/07/1997US5674492 Method of preventing or treating disease characterized by neoplastic cells expressing CD40
10/07/1997CA2041380C Use of protein c or activated protein c for preparing a pharmaceutical preparation
10/07/1997CA1339489C Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
10/02/1997WO1997035991A1 Soluble divalent and multivalent heterodimeric analogs of proteins
10/02/1997WO1997035989A2 Cyclic nucleotide phosphodiesterase
10/02/1997WO1997035986A1 Nucleic acid molecules encoding cytochrome p450-type proteins involved in the brassinosteroid synthesis in plants
10/02/1997WO1997035982A2 Monocyte chemotactic protein-5 materials and methods
10/02/1997WO1997035980A1 Antibodies against avirulence/pathogenicity proteins of plant pathogens
10/02/1997WO1997035978A1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease
10/02/1997WO1997035977A1 Polycation-sensing receptor in aquatic species and methods of use thereof
10/02/1997WO1997035976A2 Epidermal differentiation factor
10/02/1997WO1997035971A1 A NOVEL MAMMALIAN GENE, bcl-w, BELONGS TO THE bcl-2 FAMILY OF APOPTOSIS-CONTROLLING GENES
10/02/1997WO1997035966A1 Methods and compositions for cellular and metabolic engineering
10/02/1997WO1997035962A1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator
10/02/1997WO1997035961A1 Ubiquitination of the transcription factor e2a
10/02/1997WO1997035887A1 Precursors of catalytic antibodies
10/02/1997WO1997035885A1 ErbB3 ANTIBODIES
10/02/1997WO1997035884A1 Improved production of antibodies through the use of combinations of antigen and antibody, test kits incorporating said antibodies, and medical uses of said antibodies
10/02/1997WO1997035870A1 Growth factor htter36
10/02/1997WO1997035616A1 Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen
10/02/1997WO1997035614A1 The use of antibodies against cd48 for the treatment of t and b cell lymphomas and leukemias
10/02/1997WO1997035611A1 Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof
10/02/1997WO1997035610A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof
10/02/1997WO1997035600A1 Glycosylated amylins
10/02/1997WO1997026331A3 Use of neuronal apoptosis inhibitor protein (naip)
10/02/1997WO1997023611A3 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/02/1997DE19612463A1 Neues Protein mit differenzierungsinduzierender Aktivität für erythropoetische Zellen Novel protein differenzierungsinduzierender activity for erythropoietic cells
10/02/1997CA2250576A1 Monocyte chemotactic protein-5 materials and methods
10/02/1997CA2250452A1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease
10/02/1997CA2250207A1 A novel mammalian gene, bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes
10/02/1997CA2250166A1 Soluble divalent and multivalent heterodimeric analogs of proteins
10/02/1997CA2250119A1 Nucleic acid molecules encoding cytochrome p450-type proteins involved in the brassinosteroid synthesis in plants
10/02/1997CA2250069A1 Polycation-sensing receptor in aquatic species and methods of use thereof
10/02/1997CA2250034A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof
10/02/1997CA2249998A1 The use of antibodies against cd48 for the treatment of t and b cell lymphomas and leukemias
10/02/1997CA2249455A1 Precursors of catalytic antibodies
10/02/1997CA2249254A1 Epidermal differentiation factor
10/02/1997CA2249208A1 Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof
10/02/1997CA2248675A1 Cyclic nucleotide phosphodiesterase
10/02/1997CA2248318A1 Growth factor htter36
10/01/1997EP0798002A1 Inhibition of vascular stenosis
10/01/1997EP0797665A1 A kinase anchoring protein and uses thereof
10/01/1997EP0797661A1 Human mu opioid receptor
10/01/1997EP0797592A1 Human stanniocalcin-alpha
10/01/1997EP0797591A1 A novel chemokine expressed in inflamed adenoid, its production and uses
10/01/1997EP0797590A1 Neurotrophic peptides of activity dependent neurotrophic factor
10/01/1997EP0797586A1 NOVEL MEMBRANE PROTEINE p76 OF HELICOBACTER PYLORI
10/01/1997EP0797581A1 Novel protein tyrosine kinase, jak3
10/01/1997EP0797446A1 Cd40 associated proteins
10/01/1997EP0673440A4 Mammalian muscle nad:arginine adp-ribosyltransferase.
10/01/1997CA2201185A1 Anti-fas recombinant antibodies and dna therefor
09/1997
09/30/1997US5672692 Purification of human myelomonocyte interferon gamma with an immobilized antibody
09/30/1997US5672688 Immunoglobulin Fc fragment bound to an alkylating, antibiotic, or antimetabolic antitum or substance
09/30/1997US5672687 Medical diagnosis; bone marrow transplants
09/30/1997US5672683 Nerve growth factor or ciliary neurotrophic factor bound at its amino end to the carboxyl end of a transferrin, for delivery across blood brain barrier
09/30/1997US5672502 Animal cell culture
09/30/1997US5672500 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
09/30/1997US5672499 Genetic engineering; fusion gene into cell
09/30/1997US5672489 Catalytic antibodies hydrolyzing acylated carbohydrates in a regioselective and stereoselective manner
09/30/1997US5672488 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
09/30/1997US5672486 Protein polyligands joined to a stable protein core
09/30/1997US5672480 Immunoassays for prostate specific antigen
09/30/1997US5672479 Contacting sample with a solid phase matrix, where pur-protein or fragemnts are immobilized to the matrix to permit binding, removing unbound material, detecting the presence of bound material to the matrix
1 ... 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 ... 1494